Topical pharmacotherapy for skin cancer
Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, w...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Micali, Giuseppe [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
86862 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Plant uptake and translocation of contaminants of emerging concern in soil - Pullagurala, Venkata L. Reddy ELSEVIER, 2018, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:70 ; year:2014 ; number:6 ; pages:9651-96512 ; extent:86862 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jaad.2013.12.045 |
|---|
| Katalog-ID: |
ELV012174009 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV012174009 | ||
| 003 | DE-627 | ||
| 005 | 20230625110457.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaad.2013.12.045 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014006000019.pica |
| 035 | |a (DE-627)ELV012174009 | ||
| 035 | |a (ELSEVIER)S0190-9622(14)01042-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 333.7 |a 610 |q VZ |
| 084 | |a 43.12 |2 bkl | ||
| 084 | |a 43.13 |2 bkl | ||
| 084 | |a 44.13 |2 bkl | ||
| 100 | 1 | |a Micali, Giuseppe |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Topical pharmacotherapy for skin cancer |
| 264 | 1 | |c 2014transfer abstract | |
| 300 | |a 86862 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. | ||
| 520 | |a Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. | ||
| 650 | 7 | |a 5-fluorouracil |2 Elsevier | |
| 650 | 7 | |a piroxicam |2 Elsevier | |
| 650 | 7 | |a skin cancer |2 Elsevier | |
| 650 | 7 | |a dobesilate |2 Elsevier | |
| 650 | 7 | |a imiquimod |2 Elsevier | |
| 650 | 7 | |a ingenol mebutate |2 Elsevier | |
| 650 | 7 | |a resiquimod |2 Elsevier | |
| 650 | 7 | |a betulinic acid |2 Elsevier | |
| 650 | 7 | |a diclofenac |2 Elsevier | |
| 650 | 7 | |a retinoids |2 Elsevier | |
| 700 | 1 | |a Lacarrubba, Francesco |4 oth | |
| 700 | 1 | |a Nasca, Maria Rita |4 oth | |
| 700 | 1 | |a Schwartz, Robert A. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Pullagurala, Venkata L. Reddy ELSEVIER |t Plant uptake and translocation of contaminants of emerging concern in soil |d 2018 |g Amsterdam [u.a.] |w (DE-627)ELV001579983 |
| 773 | 1 | 8 | |g volume:70 |g year:2014 |g number:6 |g pages:9651-96512 |g extent:86862 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jaad.2013.12.045 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-GGO | ||
| 936 | b | k | |a 43.12 |j Umweltchemie |q VZ |
| 936 | b | k | |a 43.13 |j Umwelttoxikologie |q VZ |
| 936 | b | k | |a 44.13 |j Medizinische Ökologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 70 |j 2014 |e 6 |h 9651-96512 |g 86862 |y 70.2014, 6, 965.e1-, (86862 S.) | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
g m gm |
|---|---|
| matchkey_str |
micaligiuseppelacarrubbafrancesconascama:2014----:oiapamcteayo |
| hierarchy_sort_str |
2014transfer abstract |
| bklnumber |
43.12 43.13 44.13 |
| publishDate |
2014 |
| allfields |
10.1016/j.jaad.2013.12.045 doi GBVA2014006000019.pica (DE-627)ELV012174009 (ELSEVIER)S0190-9622(14)01042-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Micali, Giuseppe verfasserin aut Topical pharmacotherapy for skin cancer 2014transfer abstract 86862 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. 5-fluorouracil Elsevier piroxicam Elsevier skin cancer Elsevier dobesilate Elsevier imiquimod Elsevier ingenol mebutate Elsevier resiquimod Elsevier betulinic acid Elsevier diclofenac Elsevier retinoids Elsevier Lacarrubba, Francesco oth Nasca, Maria Rita oth Schwartz, Robert A. oth Enthalten in Elsevier Pullagurala, Venkata L. Reddy ELSEVIER Plant uptake and translocation of contaminants of emerging concern in soil 2018 Amsterdam [u.a.] (DE-627)ELV001579983 volume:70 year:2014 number:6 pages:9651-96512 extent:86862 https://doi.org/10.1016/j.jaad.2013.12.045 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 70 2014 6 9651-96512 86862 70.2014, 6, 965.e1-, (86862 S.) 045F 610 |
| spelling |
10.1016/j.jaad.2013.12.045 doi GBVA2014006000019.pica (DE-627)ELV012174009 (ELSEVIER)S0190-9622(14)01042-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Micali, Giuseppe verfasserin aut Topical pharmacotherapy for skin cancer 2014transfer abstract 86862 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. 5-fluorouracil Elsevier piroxicam Elsevier skin cancer Elsevier dobesilate Elsevier imiquimod Elsevier ingenol mebutate Elsevier resiquimod Elsevier betulinic acid Elsevier diclofenac Elsevier retinoids Elsevier Lacarrubba, Francesco oth Nasca, Maria Rita oth Schwartz, Robert A. oth Enthalten in Elsevier Pullagurala, Venkata L. Reddy ELSEVIER Plant uptake and translocation of contaminants of emerging concern in soil 2018 Amsterdam [u.a.] (DE-627)ELV001579983 volume:70 year:2014 number:6 pages:9651-96512 extent:86862 https://doi.org/10.1016/j.jaad.2013.12.045 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 70 2014 6 9651-96512 86862 70.2014, 6, 965.e1-, (86862 S.) 045F 610 |
| allfields_unstemmed |
10.1016/j.jaad.2013.12.045 doi GBVA2014006000019.pica (DE-627)ELV012174009 (ELSEVIER)S0190-9622(14)01042-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Micali, Giuseppe verfasserin aut Topical pharmacotherapy for skin cancer 2014transfer abstract 86862 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. 5-fluorouracil Elsevier piroxicam Elsevier skin cancer Elsevier dobesilate Elsevier imiquimod Elsevier ingenol mebutate Elsevier resiquimod Elsevier betulinic acid Elsevier diclofenac Elsevier retinoids Elsevier Lacarrubba, Francesco oth Nasca, Maria Rita oth Schwartz, Robert A. oth Enthalten in Elsevier Pullagurala, Venkata L. Reddy ELSEVIER Plant uptake and translocation of contaminants of emerging concern in soil 2018 Amsterdam [u.a.] (DE-627)ELV001579983 volume:70 year:2014 number:6 pages:9651-96512 extent:86862 https://doi.org/10.1016/j.jaad.2013.12.045 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 70 2014 6 9651-96512 86862 70.2014, 6, 965.e1-, (86862 S.) 045F 610 |
| allfieldsGer |
10.1016/j.jaad.2013.12.045 doi GBVA2014006000019.pica (DE-627)ELV012174009 (ELSEVIER)S0190-9622(14)01042-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Micali, Giuseppe verfasserin aut Topical pharmacotherapy for skin cancer 2014transfer abstract 86862 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. 5-fluorouracil Elsevier piroxicam Elsevier skin cancer Elsevier dobesilate Elsevier imiquimod Elsevier ingenol mebutate Elsevier resiquimod Elsevier betulinic acid Elsevier diclofenac Elsevier retinoids Elsevier Lacarrubba, Francesco oth Nasca, Maria Rita oth Schwartz, Robert A. oth Enthalten in Elsevier Pullagurala, Venkata L. Reddy ELSEVIER Plant uptake and translocation of contaminants of emerging concern in soil 2018 Amsterdam [u.a.] (DE-627)ELV001579983 volume:70 year:2014 number:6 pages:9651-96512 extent:86862 https://doi.org/10.1016/j.jaad.2013.12.045 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 70 2014 6 9651-96512 86862 70.2014, 6, 965.e1-, (86862 S.) 045F 610 |
| allfieldsSound |
10.1016/j.jaad.2013.12.045 doi GBVA2014006000019.pica (DE-627)ELV012174009 (ELSEVIER)S0190-9622(14)01042-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Micali, Giuseppe verfasserin aut Topical pharmacotherapy for skin cancer 2014transfer abstract 86862 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. 5-fluorouracil Elsevier piroxicam Elsevier skin cancer Elsevier dobesilate Elsevier imiquimod Elsevier ingenol mebutate Elsevier resiquimod Elsevier betulinic acid Elsevier diclofenac Elsevier retinoids Elsevier Lacarrubba, Francesco oth Nasca, Maria Rita oth Schwartz, Robert A. oth Enthalten in Elsevier Pullagurala, Venkata L. Reddy ELSEVIER Plant uptake and translocation of contaminants of emerging concern in soil 2018 Amsterdam [u.a.] (DE-627)ELV001579983 volume:70 year:2014 number:6 pages:9651-96512 extent:86862 https://doi.org/10.1016/j.jaad.2013.12.045 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 70 2014 6 9651-96512 86862 70.2014, 6, 965.e1-, (86862 S.) 045F 610 |
| language |
English |
| source |
Enthalten in Plant uptake and translocation of contaminants of emerging concern in soil Amsterdam [u.a.] volume:70 year:2014 number:6 pages:9651-96512 extent:86862 |
| sourceStr |
Enthalten in Plant uptake and translocation of contaminants of emerging concern in soil Amsterdam [u.a.] volume:70 year:2014 number:6 pages:9651-96512 extent:86862 |
| format_phy_str_mv |
Article |
| bklname |
Umweltchemie Umwelttoxikologie Medizinische Ökologie |
| institution |
findex.gbv.de |
| topic_facet |
5-fluorouracil piroxicam skin cancer dobesilate imiquimod ingenol mebutate resiquimod betulinic acid diclofenac retinoids |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Plant uptake and translocation of contaminants of emerging concern in soil |
| authorswithroles_txt_mv |
Micali, Giuseppe @@aut@@ Lacarrubba, Francesco @@oth@@ Nasca, Maria Rita @@oth@@ Schwartz, Robert A. @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV001579983 |
| dewey-sort |
3610 |
| id |
ELV012174009 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012174009</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625110457.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jaad.2013.12.045</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014006000019.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012174009</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0190-9622(14)01042-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Micali, Giuseppe</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Topical pharmacotherapy for skin cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">86862</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">5-fluorouracil</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">piroxicam</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">skin cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">dobesilate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">imiquimod</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ingenol mebutate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">resiquimod</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">betulinic acid</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">diclofenac</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">retinoids</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lacarrubba, Francesco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nasca, Maria Rita</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schwartz, Robert A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Pullagurala, Venkata L. Reddy ELSEVIER</subfield><subfield code="t">Plant uptake and translocation of contaminants of emerging concern in soil</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001579983</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:70</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:9651-96512</subfield><subfield code="g">extent:86862</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jaad.2013.12.045</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">70</subfield><subfield code="j">2014</subfield><subfield code="e">6</subfield><subfield code="h">9651-96512</subfield><subfield code="g">86862</subfield><subfield code="y">70.2014, 6, 965.e1-, (86862 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Micali, Giuseppe |
| spellingShingle |
Micali, Giuseppe ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier 5-fluorouracil Elsevier piroxicam Elsevier skin cancer Elsevier dobesilate Elsevier imiquimod Elsevier ingenol mebutate Elsevier resiquimod Elsevier betulinic acid Elsevier diclofenac Elsevier retinoids Topical pharmacotherapy for skin cancer |
| authorStr |
Micali, Giuseppe |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV001579983 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 333 - Economics of land & energy |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Topical pharmacotherapy for skin cancer 5-fluorouracil Elsevier piroxicam Elsevier skin cancer Elsevier dobesilate Elsevier imiquimod Elsevier ingenol mebutate Elsevier resiquimod Elsevier betulinic acid Elsevier diclofenac Elsevier retinoids Elsevier |
| topic |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier 5-fluorouracil Elsevier piroxicam Elsevier skin cancer Elsevier dobesilate Elsevier imiquimod Elsevier ingenol mebutate Elsevier resiquimod Elsevier betulinic acid Elsevier diclofenac Elsevier retinoids |
| topic_unstemmed |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier 5-fluorouracil Elsevier piroxicam Elsevier skin cancer Elsevier dobesilate Elsevier imiquimod Elsevier ingenol mebutate Elsevier resiquimod Elsevier betulinic acid Elsevier diclofenac Elsevier retinoids |
| topic_browse |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier 5-fluorouracil Elsevier piroxicam Elsevier skin cancer Elsevier dobesilate Elsevier imiquimod Elsevier ingenol mebutate Elsevier resiquimod Elsevier betulinic acid Elsevier diclofenac Elsevier retinoids |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
f l fl m r n mr mrn r a s ra ras |
| hierarchy_parent_title |
Plant uptake and translocation of contaminants of emerging concern in soil |
| hierarchy_parent_id |
ELV001579983 |
| dewey-tens |
610 - Medicine & health 330 - Economics |
| hierarchy_top_title |
Plant uptake and translocation of contaminants of emerging concern in soil |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV001579983 |
| title |
Topical pharmacotherapy for skin cancer |
| ctrlnum |
(DE-627)ELV012174009 (ELSEVIER)S0190-9622(14)01042-1 |
| title_full |
Topical pharmacotherapy for skin cancer |
| author_sort |
Micali, Giuseppe |
| journal |
Plant uptake and translocation of contaminants of emerging concern in soil |
| journalStr |
Plant uptake and translocation of contaminants of emerging concern in soil |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
9651 |
| author_browse |
Micali, Giuseppe |
| container_volume |
70 |
| physical |
86862 |
| class |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Micali, Giuseppe |
| doi_str_mv |
10.1016/j.jaad.2013.12.045 |
| dewey-full |
610 333.7 |
| title_sort |
topical pharmacotherapy for skin cancer |
| title_auth |
Topical pharmacotherapy for skin cancer |
| abstract |
Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. |
| abstractGer |
Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. |
| abstract_unstemmed |
Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO |
| container_issue |
6 |
| title_short |
Topical pharmacotherapy for skin cancer |
| url |
https://doi.org/10.1016/j.jaad.2013.12.045 |
| remote_bool |
true |
| author2 |
Lacarrubba, Francesco Nasca, Maria Rita Schwartz, Robert A. |
| author2Str |
Lacarrubba, Francesco Nasca, Maria Rita Schwartz, Robert A. |
| ppnlink |
ELV001579983 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.jaad.2013.12.045 |
| up_date |
2024-07-06T21:40:32.227Z |
| _version_ |
1803867423745507328 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012174009</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625110457.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jaad.2013.12.045</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014006000019.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012174009</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0190-9622(14)01042-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Micali, Giuseppe</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Topical pharmacotherapy for skin cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">86862</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Topical pharmacotherapy represents an effective alternative treatment for superficial skin cancer, primarily actinic keratoses and basal cell carcinomas. We provide an in-depth analysis of the pharmacologic aspects of available topical drugs for the treatment of primary skin tumors. In particular, we evaluate the mechanisms of action, formulations and indications, side effects, and contraindications of 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and retinoids. Moreover, the characteristics of some investigational molecules (ie, resiquimod, piroxicam, dobesilate, and betulinic acid) are presented.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">5-fluorouracil</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">piroxicam</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">skin cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">dobesilate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">imiquimod</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ingenol mebutate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">resiquimod</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">betulinic acid</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">diclofenac</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">retinoids</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lacarrubba, Francesco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nasca, Maria Rita</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schwartz, Robert A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Pullagurala, Venkata L. Reddy ELSEVIER</subfield><subfield code="t">Plant uptake and translocation of contaminants of emerging concern in soil</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001579983</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:70</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:9651-96512</subfield><subfield code="g">extent:86862</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jaad.2013.12.045</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">70</subfield><subfield code="j">2014</subfield><subfield code="e">6</subfield><subfield code="h">9651-96512</subfield><subfield code="g">86862</subfield><subfield code="y">70.2014, 6, 965.e1-, (86862 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.401005 |